Skip to content

Glaukos GKOS Return on assets

Return on assets at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
10.7%-1.3pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
11.3%-1.2pp
AbbVie logo
AbbVieABBV
2.7%-0.3pp
Boston Scientific logo
Boston ScientificBSX
8.4%+3.2pp
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
1.9%-1.5pp
Exelixis logo
ExelixisEXEL
30.7%+7.9pp

Other financials

Income statement

See full
Revenue$150.6M+41.2%
Gross profit$117.2M+42.4%
Operating income-$19.9M+4.0%
Net income-$19.8M-9.0%
EPS (diluted)-$0.34-6.3%

Balance sheet

See full
Cash & equivalents$104.2M-8.8%
Total debt$105.9M-1.7%
Total equity$670.9M-12.2%
Total assets$893.3M-7.5%

Cash flow

See full
Operating cash flow-$12.5M+32.4%
CapEx$4.0M+104%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$7.68B+12.3%
Enterprise value$7.68B+12.5%
P/S13.9×-3.0×

Profitability

See full
Gross margin78.1%+2.3pp
Operating margin-36.1%+24.3pp
Net margin-34.3%+4.8pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26.4%+11.1pp
Debt / equity0.2×0.0×
Current ratio5.4×-1.1×

Where this comes from

Calculated from Glaukos’s reported figures.

Based on trailing twelve months.

The official record: Glaukos’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Glaukos's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Glaukos's return on assets?
Glaukos (GKOS) reported return on assets of -20.4% in Q1 2026.
How has Glaukos's return on assets changed year-over-year?
Glaukos's return on assets decreased by 56.4% year-over-year, from -13% to -20.4%.
What is the long-term trend for Glaukos's return on assets?
Over 5 years (2020 to 2025), Glaukos's return on assets has grown at a 8.8% compound annual growth rate (CAGR), from -13.2% to -20.1%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.